Development of nuclease-mediated site-specific genome modification

Current Opinion in Immunology

Volumn 24, Issue 5, 2012, Pages 609-616

  Wirt, Stacey E ^a   Porteus, Matthew H ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DNA; DNA FRAGMENT; NUCLEASE; NUCLEOTIDE; ZINC FINGER NUCLEASE;

DNA MODIFICATION; DNA TEMPLATE; GENE EXPRESSION REGULATION; GENE INSERTION; GENE LOCUS; GENE MUTATION; GENE TARGETING; GENETIC ENGINEERING; HOMOLOGOUS RECOMBINATION; HUMAN; IMMUNE DEFICIENCY; MONOGENIC DISORDER; PERSONALIZED MEDICINE; REVIEW; TISSUE CULTURE CELL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CELLS, CULTURED; DNA RESTRICTION ENZYMES; GENE TARGETING; GENETIC ENGINEERING; GENOME, HUMAN; HUMANS; ZINC FINGERS;

EID: 84867743649     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2012.08.005     Document Type: Review

References (75)

1. Aiuti A., Roncarolo M.G. Ten years of gene therapy for primary immune deficiencies. Hematology Am Soc Hematol Educ Program 2009, 68:2-689.
2. Fischer A., Hacein-Bey-Abina S., Cavazzana-Calvo M. 20 years of gene therapy for SCID. Nat Immunol 2010, 11:457-460.
3. Stein S., Ott M.G., Schultze-Strasser S., Jauch A., Burwinkel B., Kinner A., Schmidt M., Kramer A., Schwable J., Glimm H., et al. Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nat Med 2010, 16:198-204.
4. Boztug K., Schmidt M., Schwarzer A., Banerjee P.P., Diez I.A., Dewey R.A., Bohm M., Nowrouzi A., Ball C.R., Glimm H., et al. Stem-cell gene therapy for the Wiskott-Aldrich syndrome. N Engl J Med 2010, 363:1918-1927.
5. Cavazzana-Calvo M., Payen E., Negre O., Wang G., Hehir K., Fusil F., Down J., Denaro M., Brady T., Westerman K., et al. Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia. Nature 2010, 467:318-322.
6. Qasim W., Gaspar H.B., Thrasher A.J. Progress and prospects: gene therapy for inherited immunodeficiencies. Gene Ther 2009, 16:1285-1291.
7. Doetschman T., Gregg R.G., Maeda N., Hooper M.L., Melton D.W., Thompson S., Smithies O. Targetted correction of a mutant HPRT gene in mouse embryonic stem cells. Nature 1987, 330:576-578.
8. Porteus M.H., Baltimore D. Chimeric nucleases stimulate gene targeting in human cells. Science 2003, 300:763.
9. Doetschman T., Maeda N., Smithies O. Targeted mutation of the Hprt gene in mouse embryonic stem cells. Proc Natl Acad Sci U S A 1988, 85:8583-8587.
10. Thomas K.R., Capecchi M.R. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 1987, 51:503-512.
11. Smithies O., Gregg R.G., Boggs S.S., Koralewski M.A., Kucherlapati R.S. Insertion of DNA sequences into the human chromosomal beta-globin locus by homologous recombination. Nature 1985, 317:230-234.
12. Sedivy J.M., Dutriaux A. Gene targeting and somatic cell genetics-a rebirth or a coming of age?. Trends Genet 1999, 15:88-90.
13. Brenneman M., Gimble F.S., Wilson J.H. Stimulation of intrachromosomal homologous recombination in human cells by electroporation with site-specific endonucleases. Proc Natl Acad Sci U S A 1996, 93:3608-3612.
14. Rouet P., Smih F., Jasin M. Introduction of double-strand breaks into the genome of mouse cells by expression of a rare-cutting endonuclease. Mol Cell Biol 1994, 14:8096-8106.
15. Choulika A., Perrin A., Dujon B., Nicolas J.F. Induction of homologous recombination in mammalian chromosomes by using the I-SceI system of Saccharomyces cerevisiae. Mol Cell Biol 1995, 15:1968-1973.
16. Donoho G., Jasin M., Berg P. Analysis of gene targeting and intrachromosomal homologous recombination stimulated by genomic double-strand breaks in mouse embryonic stem cells. Mol Cell Biol 1998, 18:4070-4078.
17. Dujon B. Group I introns as mobile genetic elements: facts and mechanistic speculations-a review. Gene 1989, 82:91-114.
18. Stoddard B.L. Homing endonucleases: from microbial genetic invaders to reagents for targeted DNA modification. Structure 2011, 19:7-15.
19. Wyman C., Kanaar R. DNA double-strand break repair: all's well that ends well. Annu Rev Genet 2006, 40:363-383.
20. Wyman C., Ristic D., Kanaar R. Homologous recombination-mediated double-strand break repair. DNA Repair (Amst) 2004, 3:827-833.
21. Paques F., Duchateau P. Meganucleases and DNA double-strand break-induced recombination: perspectives for gene therapy. Curr Gene Ther 2007, 7:49-66.
22. Porteus M.H., Carroll D. Gene targeting using zinc finger nucleases. Nat Biotechnol 2005, 23:967-973.
23. Durai S., Mani M., Kandavelou K., Wu J., Porteus M.H., Chandrasegaran S. Zinc finger nucleases: custom-designed molecular scissors for genome engineering of plant and mammalian cells. Nucleic Acids Res 2005, 33:5978-5990.
24. Bogdanove A.J., Voytas D.F. TAL effectors: customizable proteins for DNA targeting. Science 2011, 333:1843-1846.
25. Cermak T., Doyle E.L., Christian M., Wang L., Zhang Y., Schmidt C., Baller J.A., Somia N.V., Bogdanove A.J., Voytas D.F. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res 2011, 39:e82.
26. Christian M., Cermak T., Doyle E.L., Schmidt C., Zhang F., Hummel A., Bogdanove A.J., Voytas D.F. Targeting DNA double-strand breaks with TAL effector nucleases. Genetics 2010, 186:757-761.
27. Ramirez C.L., Foley J.E., Wright D.A., Muller-Lerch F., Rahman S.H., Cornu T.I., Winfrey R.J., Sander J.D., Fu F., Townsend J.A., et al. Unexpected failure rates for modular assembly of engineered zinc fingers. Nat Methods 2008, 5:374-375.
28. Maeder M.L., Thibodeau-Beganny S., Osiak A., Wright D.A., Anthony R.M., Eichtinger M., Jiang T., Foley J.E., Winfrey R.J., Townsend J.A., et al. Rapid "open-source" engineering of customized zinc-finger nucleases for highly efficient gene modification. Mol Cell 2008, 31:294-301.
29. Pruett-Miller S.M., Connelly J.P., Maeder M.L., Joung J.K., Porteus M.H. Comparison of zinc finger nucleases for use in gene targeting in mammalian cells. Mol Ther 2008, 16:707-717.
30. Urnov F.D., Miller J.C., Lee Y.L., Beausejour C.M., Rock J.M., Augustus S., Jamieson A.C., Porteus M.H., Gregory P.D., Holmes M.C. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 2005, 435:646-651.
31. Cathomen T., Joung J.K. Zinc-finger nucleases: the next generation emerges. Mol Ther 2008, 16:1200-1207.
32. Kim Y.G., Cha J., Chandrasegaran S. Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci U S A 1996, 93:1156-1160.
33. Smith J., Bibikova M., Whitby F.G., Reddy A.R., Chandrasegaran S., Carroll D. Requirements for double-strand cleavage by chimeric restriction enzymes with zinc finger DNA-recognition domains. Nucleic Acids Res 2000, 28:3361-3369.
34. Porteus M.H. Mammalian gene targeting with designed zinc finger nucleases. Mol Ther 2006, 13:438-446.
35. Moehle E.A., Rock J.M., Lee Y.L., Jouvenot Y., DeKelver R.C., Gregory P.D., Urnov F.D., Holmes M.C. Targeted gene addition into a specified location in the human genome using designed zinc finger nucleases. Proc Natl Acad Sci U S A 2007, 104:3055-3060.
36. Puck J.M., Pepper A.E., Henthorn P.S., Candotti F., Isakov J., Whitwam T., Conley M.E., Fischer R.E., Rosenblatt H.M., Small T.N., et al. Mutation analysis of IL2RG in human X-linked severe combined immunodeficiency. Blood 1997, 89:1968-1977.
37. Gaspar H.B., Gilmour K.C., Jones A.M. Severe combined immunodeficiency-molecular pathogenesis and diagnosis. Arch Dis Child 2001, 84:169-173.
38. Zou J., Sweeney C.L., Chou B.K., Choi U., Pan J., Wang H., Dowey S.N., Cheng L., Malech H.L. Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease-mediated safe harbor targeting. Blood 2011, 117:5561-5572.
39. DeKelver R.C., Choi V.M., Moehle E.A., Paschon D.E., Hockemeyer D., Meijsing S.H., Sancak Y., Cui X., Steine E.J., Miller J.C., et al. Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome. Genome Res 2010, 20:1133-1142.
40. Lombardo A., Genovese P., Beausejour C.M., Colleoni S., Lee Y.L., Kim K.A., Ando D., Urnov F.D., Galli C., Gregory P.D., et al. Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat Biotechnol 2007, 25:1298-1306.
41. Nishikawa S., Goldstein R.A., Nierras C.R. The promise of human induced pluripotent stem cells for research and therapy. Nat Rev Mol Cell Biol 2008, 9:725-729.
42. Pessach I.M., Notarangelo L.D. Primary immunodeficiency modeling with induced pluripotent stem cells. Curr Opin Allergy Clin Immunol 2011, 11:505-511.
43. Park I.H., Arora N., Huo H., Maherali N., Ahfeldt T., Shimamura A., Lensch M.W., Cowan C., Hochedlinger K., Daley G.Q. Disease-specific induced pluripotent stem cells. Cell 2008, 134:877-886.
44. Zou J., Mali P., Huang X., Dowey S.N., Cheng L. Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease. Blood 2011, 118:4599-4608.
45. Sebastiano V., Maeder M.L., Angstman J.F., Haddad B., Khayter C., Yeo D.T., Goodwin M.J., Hawkins J.S., Ramirez C.L., Batista L.F., et al. In situ genetic correction of the sickle cell anemia mutation in human induced pluripotent stem cells using engineered zinc finger nucleases. Stem Cells 2011, 29:1717-1726.
46. Hockemeyer D., Soldner F., Beard C., Gao Q., Mitalipova M., DeKelver R.C., Katibah G.E., Amora R., Boydston E.A., Zeitler B., et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat Biotechnol 2009, 27:851-857.
47. Hockemeyer D., Wang H., Kiani S., Lai C.S., Gao Q., Cassady J.P., Cost G.J., Zhang L., Santiago Y., Miller J.C., et al. Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol 2011, 29:731-734.
48. Laurent L.C., Ulitsky I., Slavin I., Tran H., Schork A., Morey R., Lynch C., Harness J.V., Lee S., Barrero M.J., et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 2011, 8:106-118.
49. Hussein S.M., Batada N.N., Vuoristo S., Ching R.W., Autio R., Narva E., Ng S., Sourour M., Hamalainen R., Olsson C., et al. Copy number variation and selection during reprogramming to pluripotency. Nature 2011, 471:58-62.
50. Zhao T., Zhang Z.N., Rong Z., Xu Y. Immunogenicity of induced pluripotent stem cells. Nature 2011, 474:212-215.
51. Pessach I.M., Ordovas-Montanes J., Zhang S.Y., Casanova J.L., Giliani S., Gennery A.R., Al-Herz W., Manos P.D., Schlaeger T.M., Park I.H., et al. Induced pluripotent stem cells: a novel frontier in the study of human primary immunodeficiencies. J Allergy Clin Immunol 2011, 127:1400-1407. e1404.
52. Kawamata M., Ochiya T. Generation of genetically modified rats from embryonic stem cells. Proc Natl Acad Sci U S A 2010, 107:14223-14228.
53. Tong C., Li P., Wu N.L., Yan Y., Ying Q.L. Production of p53 gene knockout rats by homologous recombination in embryonic stem cells. Nature 2010, 467:211-213.
54. Meyer M., de Angelis M.H., Wurst W., Kuhn R. Gene targeting by homologous recombination in mouse zygotes mediated by zinc-finger nucleases. Proc Natl Acad Sci U S A 2010, 107:15022-15026.
55. Geurts A.M., Cost G.J., Remy S., Cui X., Tesson L., Usal C., Menoret S., Jacob H.J., Anegon I., Buelow R. Generation of gene-specific mutated rats using zinc-finger nucleases. Methods Mol Biol 2010, 597:211-225.
56. Carbery I.D., Ji D., Harrington A., Brown V., Weinstein E.J., Liaw L., Cui X. Targeted genome modification in mice using zinc-finger nucleases. Genetics 2010, 186:451-459.
57. Tesson L., Usal C., Menoret S., Leung E., Niles B.J., Remy S., Santiago Y., Vincent A.I., Meng X., Zhang L., et al. Knockout rats generated by embryo microinjection of TALENs. Nat Biotechnol 2011, 29:695-696.
58. Cui X., Ji D., Fisher D.A., Wu Y., Briner D.M., Weinstein E.J. Targeted integration in rat and mouse embryos with zinc-finger nucleases. Nat Biotechnol 2011, 29:64-67.
59. Mashimo T., Takizawa A., Voigt B., Yoshimi K., Hiai H., Kuramoto T., Serikawa T. Generation of knockout rats with X-linked severe combined immunodeficiency (X-SCID) using zinc-finger nucleases. PLoS One 2010, 5:e8870.
60. Flisikowska T., Thorey I.S., Offner S., Ros F., Lifke V., Zeitler B., Rottmann O., Vincent A., Zhang L., Jenkins S., et al. Efficient immunoglobulin gene disruption and targeted replacement in rabbit using zinc finger nucleases. PLoS One 2011, 6:e21045.
61. Hauschild J., Petersen B., Santiago Y., Queisser A.L., Carnwath J.W., Lucas-Hahn A., Zhang L., Meng X., Gregory P.D., Schwinzer R., et al. Efficient generation of a biallelic knockout in pigs using zinc-finger nucleases. Proc Natl Acad Sci U S A 2011, 108:12013-12017.
62. Moreno C., Hoffman M., Stodola T.J., Didier D.N., Lazar J., Geurts A.M., North P.E., Jacob H.J., Greene A.S. Creation and characterization of a renin knockout rat. Hypertension 2011, 57:614-619.
63. Mussolino C., Morbitzer R., Lutge F., Dannemann N., Lahaye T., Cathomen T. A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity. Nucleic Acids Res 2011, 39:9283-9293.
64. Gabriel R., Lombardo A., Arens A., Miller J.C., Genovese P., Kaeppel C., Nowrouzi A., Bartholomae C.C., Wang J., Friedman G., et al. An unbiased genome-wide analysis of zinc-finger nuclease specificity. Nat Biotechnol 2011, 29:816-823.
65. Pattanayak V., Ramirez C.L., Joung J.K., Liu D.R. Revealing off-target cleavage specificities of zinc-finger nucleases by in vitro selection. Nat Methods 2011, 8:765-770.
66. Szczepek M., Brondani V., Buchel J., Serrano L., Segal D.J., Cathomen T. Structure-based redesign of the dimerization interface reduces the toxicity of zinc-finger nucleases. Nat Biotechnol 2007, 25:786-793.
67. Doyon Y., Vo T.D., Mendel M.C., Greenberg S.G., Wang J., Xia D.F., Miller J.C., Urnov F.D., Gregory P.D., Holmes M.C. Enhancing zinc-finger-nuclease activity with improved obligate heterodimeric architectures. Nat Methods 2011, 8:74-79.
68. Miller J.C., Holmes M.C., Wang J., Guschin D.Y., Lee Y.L., Rupniewski I., Beausejour C.M., Waite A.J., Wang N.S., Kim K.A., et al. An improved zinc-finger nuclease architecture for highly specific genome editing. Nat Biotechnol 2007, 25:778-785.
69. Pruett-Miller S.M., Reading D.W., Porter S.N., Porteus M.H. Attenuation of zinc finger nuclease toxicity by small-molecule regulation of protein levels. PLoS Genet 2009, 5:e1000376.
70. Li T., Huang S., Zhao X., Wright D.A., Carpenter S., Spalding M.H., Weeks D.P., Yang B. Modularly assembled designer TAL effector nucleases for targeted gene knockout and gene replacement in eukaryotes. Nucleic Acids Res 2011, 39:6315-6325.
71. Huang P., Xiao A., Zhou M., Zhu Z., Lin S., Zhang B. Heritable gene targeting in zebrafish using customized TALENs. Nat Biotechnol 2011, 29:699-700.
72. Mak A.N., Bradley P., Cernadas R.A., Bogdanove A.J., Stoddard B.L. The crystal structure of TAL effector PthXo1 bound to its DNA target. Science 2012, 335:716-719.
73. Deng D., Yan C., Pan X., Mahfouz M., Wang J., Zhu J.K., Shi Y., Yan N. Structural basis for sequence-specific recognition of DNA by TAL effectors. Science 2012, 335:720-723.
74. van Rensburg R., Beyer I., Yao X.Y., Wang H., Denisenko O., Li Z.Y., Russell D.W., Miller D.G., Gregory P., Holmes M., et al. Chromatin structure of two genomic sites for targeted transgene integration in induced pluripotent stem cells and hematopoietic stem cells. Gene Ther 2012, 10.1038/gt.2012.25.
75. Holt N., Wang J., Kim K., Friedman G., Wang X., Taupin V., Crooks G.M., Kohn D.B., Gregory P.D., Holmes M.C., et al. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol 2010, 28:839-847.